Related references
Note: Only part of the references are listed.Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine in Healthy Boys Aged 10-18 Years
Tiina Petaja et al.
JOURNAL OF ADOLESCENT HEALTH (2009)
Human Papillomavirus (HPV) Vaccines: Limited Cross-Protection against Additional HPV Types
Rolando Herrero
JOURNAL OF INFECTIOUS DISEASES (2009)
HPV Screening for Cervical Cancer in Rural India
Rengaswamy Sankaranarayanan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China
You-lin Qiao et al.
LANCET ONCOLOGY (2008)
Mathematical Models of Cervical Cancer Prevention in Latin America and the Caribbean
Sue J. Goldie et al.
VACCINE (2008)
Introduction of Human Papillomavirus Vaccines into Developing Countries - International Strategies for Funding and Procurement
Jon Kim Andrus et al.
VACCINE (2008)
Cervical Cancer Screening Programs in Latin America and the Caribbean
Raul Murillo et al.
VACCINE (2008)
Human Papillomavirus Vaccine Policy and Delivery in Latin America and the Caribbean
Jon Kim Andrus et al.
VACCINE (2008)
Risk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the Caribbean
Maribel Almonte et al.
VACCINE (2008)
Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006-January 2008
Anna Koulova et al.
VACCINE (2008)
An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results
John T. Schiller et al.
VACCINE (2008)
Cost-effectiveness of conventional cytology and HPV DNA testing for cervical cancer screening in Colombia
Oscar Andres-Gamboa et al.
SALUD PUBLICA DE MEXICO (2008)
Social inequality in Pap smear coverage: identifying under-users of cervical cancer screening in Argentina
Silvina Arrossi et al.
REPRODUCTIVE HEALTH MATTERS (2008)
Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications
Sue J. Goldie et al.
REPRODUCTIVE HEALTH MATTERS (2008)
Human papillomavirus and cervical cancer
Mark Schiffman et al.
LANCET (2007)
Human papillomavirus and HPV vaccines: a review
F. T. Cutts et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2007)
Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial
Rengaswamy Sankaranarayanan et al.
LANCET (2007)
Modeling the long-term antibody response of a human papillomavirus (HPV) virus-like particle (VLP) type 16 prophylactic vaccine
Christophe Fraser et al.
VACCINE (2007)
Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing
Cosette M. Wheeler
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Issues in planning cervical cancer screening in the era of HPV vaccination
Eduardo L. Franco et al.
VACCINE (2006)
Modelling the impact of HPV vaccines on cervical cancer and screening programmes
Geoffrey P. Garnett et al.
VACCINE (2006)
Research needs following initial licensure of virus-like particle HPV vaccines
Allan Hildesheim et al.
VACCINE (2006)
Second generation HPV vaccines to prevent cervical cancer
John T. Schiller et al.
VACCINE (2006)
Education, training, and communication for HPV vaccines
Jacqueline Sherris et al.
VACCINE (2006)
Psychosocial aspects of vaccine acceptability
Gregory D. Zimet et al.
VACCINE (2006)
Human papillomavirus vaccines
Mia R. Schmiedeskamp et al.
ANNALS OF PHARMACOTHERAPY (2006)
Future acceptance of adolescent human papillomavirus vaccination: A survey of parental attitudes
L Brabin et al.
VACCINE (2006)
Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams
PM Muñoz et al.
VACCINE (2006)
Cost-effectiveness of cervical-cancer screening in five developing countries
SJ Goldie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A critical assessment of screening methods for cervical neoplasia
R Sankaranarayanan et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2005)
Potential health and economic impact of adding a human papillomavirus vaccine to screening programs
SL Kulasingam et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Prevention of cervical cancer in resource-poor settings - Reply
L Gaffikin
LANCET (2003)
Human papillomavirus types in invasive cervical cancer worldwide:: a meta-analysis
GM Clifford et al.
BRITISH JOURNAL OF CANCER (2003)
Share Paper
